“Co-Treatment With Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Suppresses Radiotherapy-Induced Epithelial-to-Mesenchymal Transition, Cancer Cell Stemness, and Lung Metastasis of Breast Cancer: ALK5 Inhibitor Suppressed Radiation Induced Metastasis”. 2022. Radiology and Oncology 56 (2): 185-97. https://www.ojstest.computing.si/index.php/ro/article/view/3779.